Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ildiko Lingvay

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2017
SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUOIldiko Lingvay
Lancet (London, England)|June 6, 2026
Multireceptor modulation in metabolic disease: are more targets better?Shuyao Zhang, Ildiko Lingvay
Expert Review of Cardiovascular Therapy|March 29, 2011
Hepatic steatosis and Type 2 diabetes: current and future treatment considerationsJohn Richard, Ildiko Lingvay
Expert Review of Cardiovascular Therapy|April 20, 2010
Is insulin treatment a first-line defense against Type 2 diabetes?John Richard, Ildiko Lingvay
Nature Reviews. Endocrinology|November 21, 2023
SGLT inhibitors: a serendipitous glycaemic taleShubham Agarwal, Ildiko Lingvay
Nature Medicine|September 22, 2023
A revolution in obesity treatmentIldiko Lingvay, Shubham Agarwal
Evidence-Based Medicine|August 30, 2012
Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetesLindsay Bundrick Harrison, Ildiko Lingvay
Current Diabetes Reports|October 25, 2017
The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?Laurentiu M Pop, Ildiko Lingvay
Circulation|May 23, 2018
Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical GuideIldiko Lingvay, Lawrence A Leiter
Obesity (Silver Spring, Md.)|November 5, 2023
Encouraging but slow progress toward incorporating obesity care into diabetes careJaime P Almandoz, Ildiko Lingvay
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2017
SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUOIldiko Lingvay
Lancet (London, England)|June 6, 2026
Multireceptor modulation in metabolic disease: are more targets better?Shuyao Zhang, Ildiko Lingvay
Expert Review of Cardiovascular Therapy|March 29, 2011
Hepatic steatosis and Type 2 diabetes: current and future treatment considerationsJohn Richard, Ildiko Lingvay
Expert Review of Cardiovascular Therapy|April 20, 2010
Is insulin treatment a first-line defense against Type 2 diabetes?John Richard, Ildiko Lingvay
Nature Reviews. Endocrinology|November 21, 2023
SGLT inhibitors: a serendipitous glycaemic taleShubham Agarwal, Ildiko Lingvay
Nature Medicine|September 22, 2023
A revolution in obesity treatmentIldiko Lingvay, Shubham Agarwal
Evidence-Based Medicine|August 30, 2012
Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetesLindsay Bundrick Harrison, Ildiko Lingvay
Current Diabetes Reports|October 25, 2017
The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?Laurentiu M Pop, Ildiko Lingvay
Circulation|May 23, 2018
Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical GuideIldiko Lingvay, Lawrence A Leiter
Obesity (Silver Spring, Md.)|November 5, 2023
Encouraging but slow progress toward incorporating obesity care into diabetes careJaime P Almandoz, Ildiko Lingvay
Pageof 22